Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Join the club for FREE to access the whole archive and other member benefits.
Co-founder of NeuroAge Therapeutics and Research Fellow at University of California, Berkeley
Priyanka Joshi is a biochemist who is an Everitt Butterfield research fellow at Downing College, Cambridge. She works at the university's Centre for Misfolding Diseases, studying the metabolic precursors which influence the aggregation of proteins such as amyloid beta which are thought to cause Alzheimer's disease. In 2018, she was listed in the Forbes "30 under 30" list of innovators in science and healthcare and the Vogue 25 list of influential women in Britain.
Joshi was born in Delhi, India in 1988. She went to Mount Carmel School in Delhi and then studied for a MSc in Biotechnology at Savitribai Phule Pune University before gaining a PhD at the University of Cambridge in Chemistry. She was awarded the Salje medal for Best PhD in Science by Clare Hall, Cambridge in 2015.
Visit website: https://prijoshi.com/home
priyanka-joshi-cambridge-berkeley
See also: NeuroAge Therapeutics - Longevity pharmatech that creates drugs to rejuvenate biological brain aging and treat neurodegenerative disorders
Details last updated 27-Dec-2022
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials